Combinatorial chemistry for the synthesis of non-peptide organic compounds has emerged as an important tool for drug discovery. 1 Solid-phase synthesis of substituted heterocyclic compounds in particular has been a focus of recent investigations with application toward a variety of drug targets.
2 As a part of our project to develop efficient synthetic methods for heterocyles, 3 we have investigated the solid-phase synthesis of 2,1,3-benzothiadiazin-4-one 2-oxides as they are similar to other important heterocycles such as quinazoline-2,4-diones, 3d,4 2-thioxoquinazolin-4-ones, 3a ,3c 4-quinazolinones, 3b,5 1,2,4-benzothiadiazine 1,1-dioxide, 3e 1,2,4-benzothiadiazin-3-one 1,1-dioxide, 3f benzimidazole, 6 hydantoin, 7 2-piperazinone 8 Since these heterocycles have been prepared from solid-supported primary amines including nitrogen atoms as parts of the heterocycles, they can easily be compared to bioactivities of 2,1,3-benzothiadiazin-4-one 2-oxides by developing the appropriate solid-phase chemistry ( Figure 1 ). Nevertheless, to the best of our knowledge, there has been only one report of the synthesis of 2,1,3-benzothiadiazin-4-one 2-oxides in solutionphase. 9 2,1,3-Benzothiadiazin-4-one 2-oxides were synthesized by reacting 2-(alkylamino)benzamides with conc. thionylchloride under reflux in the previous report; however, this reaction is not suitable for our solid-phase synthesis as the compounds on solid-support would be cleaved under such acidic condition. Thus, investigation was required for thionylation on solid-support. In addition, preparation of diverse 2-(alkylamino)benzamide was difficult with the reported method; therefore, we decided to prepare 2-(alkylamino)-benzamides from 2-fluoro-5-nitrobenzamides through S N Ar reaction. The key building block, 2-fluoro-5-nitrobenzoic acid, was successfully applied to the solid-phase synthesis of various heterocycles, such as benzimidazoles, 10 benzopiperazinones, 11 macrocycles, 12 1,4-benzothiazepin-5-ones, 13 quinazoline-2,4-diones, 3d 2-thioxoquinazolin-4-ones. 3c Here, we report the solid-phase synthesis of 2,1,3-benzothiadiazin-4-one 2-oxides. SynPhase TM Lantern 14 bearing 4-aminobenzoic acid ester 1 was prepared as previously described. 3a Then, 1 was reacted with 2-fluoro-5-nitrobenzoic acid 2 activated with N,N'-diisopropylcarbodiimide (DIC)/1-hydroxy-7-azabenzotriazole (HOAt). Preactivation of 2 is important to prevent solid-supported amine 1 from reacting with 2 or DIC. S N Ar type reaction was performed by treating 3 with various primary amines 4 to give 5 with high purity. Next, cyclization of 5 was attempted using thionylchloride 6. Although various reaction conditions such as the base (diisopropylethylamine {DIEA}, pyridine, 2,6-lutidine, 2,4,6-collidine), solvents (dichloromethane {DCM}, THF, 1,4-dioxane) and reaction temperature (0-25 o C) were examined, 7 was obtained together with unknown byproducts. Therefore, thionylchloride was converted into more stable reagents with several additives (tetrazole, 1,2,4-triazole, imidazole) prior to the addition to the Lantern, and the treatment of 5 with thionylchloride/ 1,2,4-triazole/DIEA/DCM was found to give 2,1,3-benzo- Notes thiadiazin-4-one 2-oxides 8 in high purity. (Table 1 , Entry ah). In addition, various solid-supported arylamines prepared from the corresponding nitrobenzenes were derivatized by the same procedure to give 2,1,3-benzothiadiazin-4-one 2-oxides in high purity (Entry i-l), showing the procedure is suitable for an array of compounds. Furthermore, the nitro group at the 6-position of 2,1,3-benzothiadiazin-4-one 2-oxides was successfully reduced with SnCl 2 ·2H 2 O/EtOH/ NMP to offer the additional diversity point. 16 In conclusion, the solid-phase synthesis of 2,1,3-benzothiadiazin-4-one 2-oxides has been successfully achieved for the first time. Various 2,1,3-benzothiadiazin-4-one 2-oxides can be synthesized with high purity. In addition, bioactivities of 2,1,3-benzothiadiazin-4-one 2-oxides can be efficiently compared with those of other important pharmacophores as described above.
General procedure for preparation of 4-(2-oxido-4-oxo-1-propyl-1,4-dihydro-3H-2,1,3-benzothiadiazin-3-yl)benzoic acid (8a). SynPhase TM lantern (SP-PS-D-HMP, loading 35 µmol/lantern) bearing the 4-aminobenzoic acid ester was put into 2.5-mL syringe. After 2-fluoro-5-nitrobenzoic acid (1.0 mmol) was activated with DIC/HOAt / NMP (0.5 mmol/1.0 mmol/2 mL) at 25 °C for 1 h, this solution was added to the syringe. After shaking the syringe for 16 h, the resin was washed with dry DMF (2 mL × 3) and dry DCM (2 mL × 3), and dried under a vacuum for 1 h. After isopropylamine/ NMP (200 mL/1.0 mL) was added, the syringe was shaken for 3 h and the resin was washed with DMF (2 mL × 3) and DCM (2 mL × 3). Then, the mixture of thionyl chloride/ triazole/DIEA/DCM (80 uL/250 mg/400 uL/1 mL) was added to the syringe, and the syringe was shaken for 16 h. After washing the resin with DCM (2 mL × 2), DMF (2 mL × 3) and DCM (2 mL × 3), the resin was dried under a vacuum for 3 h. The resin was treated with 95% TFA/H 2 O for 1 h and the filtrate was concentrated with Genevac evaporator. The residue was dissolved with 50% CH 3 CN/ H 2 O and lyophilized to give the crude product.
(11.7 mg, yield 86%) Isobutyl-2-oxido-4-oxo-1,4-dihydro-3H-2,1,3 -benzothiadiazin-3-yl)benzoic acid (8c). Prepared as described above, using isobutylamine. + . Cyclopropyl-2-oxido-4-oxo-1,4-dihydro-3H-2,1,3 benzothiadiazin-3-yl)benzoic acid (8d). Prepared as described above, using cyclopropylamine. (12.6 mg, yield 93%) 1 H Scheme 1. Synthetic scheme for 2,1,3-Benzothiadiazin-4-one 2-oxides. Table 1 . Synthesis of 2,1,3-Benzothiadiazin-4-one 2-oxides using various amines 4 and several derivatized Lanterns Cyclobutyl-2-oxido-4-oxo-1,4-dihydro-3H-2,1,3-benzothiadiazin-3-yl)benzoic acid (8e) . Prepared as described above, using cyclobutylamine. (13.5 mg, yield 96%) 1 )-2-oxido-4-oxo-1,4-dihydro-3H-2,1,3-benzothiadiazin-3-yl]benzoic acid (8f) . Prepared as described above, using cyclohexanemethylamine. -4-oxo-1-propyl-1,4-dihydro-3H-2,1,3 -benzothiadiazin-3-yl)benzoic acid (8i). Prepared as described above, using 3-aminobenzoic acid. 2E)-3-[3-(2-Oxido-4-oxo-1-propyl-1,4-dihydro-3H-2,1, 3-benzothiadiazin-3-yl)phenyl]-2-propenoic acid (8k). Prepared as described above, using 3-aminocinnamic acid. 2E)-3-[4-(2-Oxido-4-oxo-1-propyl-1,4-dihydro-3H-2,1,  3-benzothiadiazin-3-yl)phenyl]-2-propenoic acid (8l) . Prepared as described above, using 4-aminocinnamic acid. + .
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